The expression profile of growth factors involved in OPC recruitment (PDGFRa, FGF2) and in OPC differentiation (IGF1, TGF1) following demyelination is altered in old mice, in which the upregulation of these factors is both weaker and delayed (Hinks and Franklin, Consistent with cell-autonomous effects, the epigenetic control of OPC differentiation into myelinating OLGs is disrupted with aging (Shen et al., 2008), and the OPCs of aged mice fail to respond to growth factors and differentiation signals (Neumann et al., 2019)
After three months of twice-daily application, the Pure Copper peptide treatment group demonstrated superior outcomes in reducing lines and wrinkles, improving skin density, and increasing dermal thickness compared to both control groups
BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, KPV is a tripeptide fragment of -MSH, PEA (palmitoylethanolamide) is a naturally occurring fatty acid amide, and Tributyrin is a prodrug of butyric acid
Clinically studied for its regenerative properties, BPC-157 has been shown to enhance blood flow to damaged tissues, protect internal organs, and accelerate recovery across a range of injury types
Dosages used in rodent studies range from 10mg/kg/day to 150mg/kg/day [1, 6, 11]
